158 related articles for article (PubMed ID: 25294622)
1. Distance to Cannabis Shops and Age of Onset of Cannabis Use.
Palali A; van Ours JC
Health Econ; 2015 Nov; 24(11):1483-501. PubMed ID: 25294622
[TBL] [Abstract][Full Text] [Related]
2. Buying cannabis in 'coffee shops'.
Monshouwer K; Van Laar M; Vollebergh WA
Drug Alcohol Rev; 2011 Mar; 30(2):148-56. PubMed ID: 21375615
[TBL] [Abstract][Full Text] [Related]
3. The long and winding road to cannabis legalization.
Van Ours JC
Addiction; 2012 May; 107(5):872-3. PubMed ID: 22471565
[No Abstract] [Full Text] [Related]
4. Tightening the Dutch coffee shop policy: Evaluation of the private club and the residence criterion.
van Ooyen-Houben MM; Bieleman B; Korf DJ
Int J Drug Policy; 2016 May; 31():113-20. PubMed ID: 26944718
[TBL] [Abstract][Full Text] [Related]
5. Practical experience with legalized cannabis.
Gieringer D
Addiction; 2012 May; 107(5):875-6. PubMed ID: 22471567
[No Abstract] [Full Text] [Related]
6. Cannabis decriminalization and the age of onset of cannabis use.
Červený J; Chomynová P; Mravčík V; van Ours JC
Int J Drug Policy; 2017 May; 43():122-129. PubMed ID: 28395168
[TBL] [Abstract][Full Text] [Related]
7. What can we learn from the Dutch cannabis coffeeshop system?
MacCoun RJ
Addiction; 2011 Nov; 106(11):1899-910. PubMed ID: 21906196
[TBL] [Abstract][Full Text] [Related]
8. New regulated markets for recreational cannabis: public health or private profit?
Lenton S
Addiction; 2014 Mar; 109(3):354-5. PubMed ID: 24524314
[No Abstract] [Full Text] [Related]
9. Limitations to the Dutch cannabis toleration policy: Assumptions underlying the reclassification of cannabis above 15% THC.
Van Laar M; Van Der Pol P; Niesink R
Int J Drug Policy; 2016 Aug; 34():58-64. PubMed ID: 27471078
[TBL] [Abstract][Full Text] [Related]
10. Attitudes of cannabis growers to regulation of cannabis cultivation under a non-prohibition cannabis model.
Lenton S; Frank VA; Barratt MJ; Dahl HV; Potter GR
Int J Drug Policy; 2015 Mar; 26(3):257-66. PubMed ID: 25181993
[TBL] [Abstract][Full Text] [Related]
11. Qualitative research in Spanish cannabis social clubs: "The moment you enter the door, you are minimising the risks".
Belackova V; Tomkova A; Zabransky T
Int J Drug Policy; 2016 Aug; 34():49-57. PubMed ID: 27461986
[TBL] [Abstract][Full Text] [Related]
12. The Dangerous Drugs Act Amendment in Jamaica: Reviewing goals, implementation, and challenges.
Davenport S; Pardo B
Int J Drug Policy; 2016 Nov; 37():60-69. PubMed ID: 27596698
[TBL] [Abstract][Full Text] [Related]
13. "Should I Buy or Should I Grow?" How drug policy institutions and drug market transaction costs shape the decision to self-supply with cannabis in the Netherlands and the Czech Republic.
Belackova V; Maalsté N; Zabransky T; Grund JP
Int J Drug Policy; 2015 Mar; 26(3):296-310. PubMed ID: 25655217
[TBL] [Abstract][Full Text] [Related]
14. Does liberalizing cannabis laws increase cannabis use?
Williams J; Bretteville-Jensen AL
J Health Econ; 2014 Jul; 36():20-32. PubMed ID: 24727348
[TBL] [Abstract][Full Text] [Related]
15. Underbanked: Cooperative Banking as a Potential Solution to the Marijuana-Banking Problem.
Tighe PA
Mich Law Rev; 2016; 114(5):803-32. PubMed ID: 27008718
[TBL] [Abstract][Full Text] [Related]
16. The green (and winding) road. It's been a year since Colorado and Washington legalized recreational marijuana, and not all that was predicted has come to pass--with some surprises along the way.
Weiss S
State Legis; 2015 Mar; 41(3):20-3, 24. PubMed ID: 25946753
[No Abstract] [Full Text] [Related]
17. Let it grow-the open market solution to marijuana control.
Gettman J; Kennedy M
Harm Reduct J; 2014 Nov; 11(1):32. PubMed ID: 25403234
[TBL] [Abstract][Full Text] [Related]
18. Design considerations for legalizing cannabis: lessons inspired by analysis of California's Proposition 19.
Caulkins JP; Kilmer B; MacCoun RJ; Pacula RL; Reuter P
Addiction; 2012 May; 107(5):865-71. PubMed ID: 21985069
[TBL] [Abstract][Full Text] [Related]
19. Local politics and retail cannabis markets: the case of the Dutch coffeeshops.
Wouters M; Benschop A; Korf DJ
Int J Drug Policy; 2010 Jul; 21(4):315-20. PubMed ID: 20116988
[TBL] [Abstract][Full Text] [Related]
20. Additional considerations.
Nadelmann E; Gutwillig S; Davies J
Addiction; 2012 May; 107(5):873-5. PubMed ID: 22471566
[No Abstract] [Full Text] [Related]
[Next] [New Search]
